← All organizations

VaxDesign

For profitWebsite ↗

Also known as: VaxDesign Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jul 12, 2017

Acquired by Sanofi-Aventis on Sep 27, 2010

Timeline

2000s

Jan 1, 2003
VaxDesign— Founded

2010s

Sep 27, 2010
Sanofi-Aventis— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 4 (1 own, 0 via acquisition)

acellular pertussis vaccine (including diptheria and tetanus toxoids)

Indications

Studied for

Whooping Cough

Recent trials (1)

NCT04543669CollaboratorPhase 4Jul 12, 2017

Details

Founded: Orlando, FL, US Jan 1, 2003
Last known activity: Jul 12, 2017